Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2009-04-22 | Jason M. Aryeh, age 40, has been a director of the Company since 2006. He is the founder and general partner of JALAA Equities, LP, a private hedge fund formed in 1996 with a focus on biotechnology and specialty pharmaceutical companies. Mr. Aryeh also serves on the board of directors of Ligand Pharmaceuticals. The Nominating and Governance Committee currently consists of Messrs. Aryeh and Harvey, Ms. Jenckes and Mr. Sudovar (Chairman). The following table sets forth compensation actually paid, earned or accrued during fiscal year 2008 by the Companys directors. Jason Aryeh Fees Earned or Paid in Cash $52,000, Option Awards $52,200, Total $104,200. |
| 2010-04-16 | Jason M. Aryeh, age 41, has been a director of the Company since 2006. ... Mr. Aryeh's experience in the biotechnology industry ... were among the factors considered by the Board of Directors in determining that Mr. Aryeh should be nominated for election as a director. ... The Nominating and Governance Committee currently consists of Messrs. Aryeh and Harvey, Ms. Jenckes and Mr. Sudovar (Chairman). ... The following table sets forth compensation actually paid, earned or accrued during fiscal year 2009 by the Company's directors. Jason Aryeh Fees Earned or Paid in Cash 40,500 Option Awards 40,543 All Other Compensation 12,656 Total 93,699 |
| 2011-04-20 | Jason M. Aryeh, age 42, has been a director of the Company since 2006. ... Mr. Aryeh's experience in the biotechnology industry... The Compensation Committee currently consists of Messrs. Harvey (Chairman), Aryeh and Cox... The following table sets forth compensation actually paid, earned or accrued during fiscal year 2010 by the Company's directors. Jason Aryeh 33,500 Fees Earned or Paid in Cash, 68,044 Option Awards, 101,544 Total. |
Data sourced from SEC filings. Last updated: 2025-07-01